U S Physical Therapy Inc. (USPH) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
U S Physical Therapy’s revenue went from $357M in fiscal 2016 to $781M in fiscal 2025, growth of about 9.1% a year.
Net income in fiscal 2025 was $40M, a net margin of 5.1%; the best year in this period was 2021 with $41M.
Over the twelve months to September 30, 2026, revenue was $838M and net income $30M.
Free cash flow was $61M in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count rose 21% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $838M | $781M | $671M | $605M | $553M | $495M | $423M | $482M | $454M | $414M | $357M |
| Gross profit | $158M | $150M | $124M | $122M | $112M | $117M | $94M | $112M | $102M | $91M | $82M |
| Operating income | $76M | $87M | $63M | $51M | $57M | $71M | $52M | $67M | $60M | $55M | $50M |
| Net income | $30M | $40M | $31M | $28M | $32M | $41M | $35M | $40M | $35M | $22M | $21M |
| EPS (diluted) | $-1.34 | $1.42 | $1.84 | $1.28 | $2.25 | $2.41 | $2.48 | $2.45 | $1.31 | $1.76 | $1.64 |
| R&D | — | — | — | — | — | — | — | — | — | — | — |
| Revenue growth | — | +16.3% | +11.0% | +9.3% | +11.7% | +17.0% | −12.2% | +6.2% | +9.6% | +16.1% | — |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $89M | $75M | $75M | $82M | $59M | $76M | $100M | $62M | $73M | $57M | $51M |
| Capital spending | -$20M | -$14M | -$9M | -$9M | -$8M | -$8M | -$8M | -$10M | -$7M | -$7M | -$8M |
| Free cash flow | $69M | $61M | $66M | $73M | $50M | $68M | $92M | $52M | $66M | $49M | $43M |
| Dividends paid | $28M | $27M | $27M | $24M | $21M | $19M | $4M | $15M | $12M | $10M | $9M |
| Buybacks | $25M | $6M | $0 | $0 | — | — | — | — | — | — | — |
| Stock-based pay | $11M | $8M | $8M | $7M | $7M | $8M | $8M | $7M | $6M | $5M | $5M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $36M | $41M | $153M | $32M | $29M | $33M | $24M | $23M | $22M | $20M |
| Debt | — | $315M | $295M | $259M | $295M | $223M | $111M | $138M | $40M | $61M | $52M |
| Equity | — | $476M | $489M | $476M | $316M | $296M | $276M | $240M | $216M | $205M | $188M |
| Total assets | — | $1.2B | $1.2B | $997M | $858M | $749M | $594M | $631M | $443M | $419M | $351M |
| Shares (diluted) | 15M | 15M | 15M | 14M | 13M | 13M | 13M | 13M | 13M | 13M | 12M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 18.8% | 19.2% | 18.5% | 20.1% | 20.2% | 23.7% | 22.3% | 23.3% | 22.4% | 21.9% | 23.0% |
| Operating margin | 9.1% | 11.1% | 9.4% | 8.3% | 10.3% | 14.3% | 12.4% | 14.0% | 13.3% | 13.2% | 13.9% |
| Net margin | 3.6% | 5.1% | 4.7% | 4.7% | 5.8% | 8.2% | 8.3% | 8.3% | 7.7% | 5.4% | 5.8% |
| FCF margin | 8.2% | 7.8% | 9.8% | 12.0% | 9.1% | 13.8% | 21.8% | 10.8% | 14.5% | 11.9% | 12.0% |
| ROIC | — | 8.2% | 6.1% | 5.2% | 7.3% | 10.8% | 10.8% | 14.4% | 19.1% | 16.9% | 14.2% |
| ROE | — | 8.3% | 6.4% | 5.9% | 10.2% | 13.8% | 12.7% | 16.7% | 16.2% | 10.9% | 11.0% |
Frequently asked questions
What is U S Physical Therapy’s annual revenue?
$781M in fiscal 2025 and $838M over the twelve months to September 30, 2026.
How much profit does U S Physical Therapy make?
Net income was $40M in fiscal 2025 (net margin 5.1%).
Is U S Physical Therapy’s revenue growing?
Yes: revenue rose 16.3% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.